JP2011526288A5 - - Google Patents

Download PDF

Info

Publication number
JP2011526288A5
JP2011526288A5 JP2011516610A JP2011516610A JP2011526288A5 JP 2011526288 A5 JP2011526288 A5 JP 2011526288A5 JP 2011516610 A JP2011516610 A JP 2011516610A JP 2011516610 A JP2011516610 A JP 2011516610A JP 2011526288 A5 JP2011526288 A5 JP 2011526288A5
Authority
JP
Japan
Prior art keywords
implantable device
delivery
polypeptide
surface area
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011516610A
Other languages
English (en)
Japanese (ja)
Other versions
JP5622725B2 (ja
JP2011526288A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/048475 external-priority patent/WO2009158412A2/en
Publication of JP2011526288A publication Critical patent/JP2011526288A/ja
Publication of JP2011526288A5 publication Critical patent/JP2011526288A5/ja
Application granted granted Critical
Publication of JP5622725B2 publication Critical patent/JP5622725B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011516610A 2008-06-25 2009-06-24 エキセナチド及び他のポリペプチド類の持続的送達 Expired - Fee Related JP5622725B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7562508P 2008-06-25 2008-06-25
US61/075,625 2008-06-25
PCT/US2009/048475 WO2009158412A2 (en) 2008-06-25 2009-06-24 Sustained delivery of exenatide and other polypeptides

Publications (3)

Publication Number Publication Date
JP2011526288A JP2011526288A (ja) 2011-10-06
JP2011526288A5 true JP2011526288A5 (https=) 2012-05-24
JP5622725B2 JP5622725B2 (ja) 2014-11-12

Family

ID=41111133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011516610A Expired - Fee Related JP5622725B2 (ja) 2008-06-25 2009-06-24 エキセナチド及び他のポリペプチド類の持続的送達

Country Status (4)

Country Link
US (3) US8071537B2 (https=)
EP (1) EP2303226B1 (https=)
JP (1) JP5622725B2 (https=)
WO (1) WO2009158412A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
UA104866C2 (uk) * 2008-06-25 2014-03-25 Ендо Фармас'Ютікалз Солюшнз Інк. Імплантат октреотиду, який містить вивільняючу речовину
JP6149183B2 (ja) 2011-10-24 2017-06-21 ブレイバーン ファーマシューティカルズ,インコーポレイティド 移植可能チザニジン組成物及びその治療方法
SG10201604104PA (en) 2011-10-25 2016-07-28 Prothena Therapeutics Ltd Antibody formulations and methods
CN105209074A (zh) 2012-10-20 2015-12-30 得克萨斯大学体系董事会 癌细胞陷阱
US9669405B2 (en) * 2012-10-22 2017-06-06 The Regents Of The University Of California Sterilizable photopolymer serum separator
WO2021173770A1 (en) 2020-02-28 2021-09-02 Nano Precision Medical, Inc. Polymeric stabilizing agents for implantable drug delivery devices
AU2016267052B2 (en) 2015-05-22 2022-01-20 The Bot Of The Leland Stanford Junior University Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
US10653753B2 (en) 2016-03-04 2020-05-19 Eiger Biopharmaceuticals, Inc. Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
EP3515408A1 (en) * 2016-09-23 2019-07-31 Delpor, Inc. Stable compositions for incretin mimetic compounds
EP4591853A1 (en) 2016-11-21 2025-07-30 Amylyx Pharmaceuticals, Inc. Buffered formulations of exendin (9-39)
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
TWI829687B (zh) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
US11690806B2 (en) * 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
MX2020014160A (es) * 2018-06-25 2021-03-09 Titan Pharmaceuticals Inc Implantes para liberacion de sustancias farmaceuticas lipofilicas o anfifilicas.
CA3116906A1 (en) * 2018-11-02 2020-05-07 Bionaut Labs Ltd. Magnetomechanic triggering of payload release from miniaturized devices
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
WO2024036108A1 (en) * 2022-08-09 2024-02-15 Bionaut Labs Ltd. Devices, systems, and methods for the treatment of malignant neoplasm disorders using controlled release devices

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2168331A (en) 1936-10-17 1939-08-08 Du Pont Cast resin with integral sheen
US2513014A (en) * 1946-11-18 1950-06-27 Abbott Lab Apparatus for implanting medicinal pellets subcutaneously
GB1306541A (en) 1969-01-20 1973-02-14 Ceskoslovenska Akademie Ved Method of manufacturing tubes by centrifugal casting
US3921632A (en) * 1974-08-16 1975-11-25 Frank M Bardani Implant device
US4131604A (en) * 1977-11-23 1978-12-26 Thermo Electron Corporation Polyurethane elastomer for heart assist devices
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4386039A (en) * 1980-02-11 1983-05-31 Thermo Electron Corporation Process for forming an optically clear polyurethane lens or cornea
US4523005A (en) * 1981-10-30 1985-06-11 Thermedics, Inc. Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol, and 1,4-butane diol
US4751133A (en) 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US4860110A (en) * 1986-05-06 1989-08-22 Canon Kabushiki Kaisha Communication terminal device
US5342622A (en) * 1986-05-16 1994-08-30 The State Of Victoria Subdermal biocompatible implants
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4743673A (en) * 1986-12-19 1988-05-10 Tyndale Plains-Hunter, Ltd. Hydrophilic carboxy polyurethanes
US4871094A (en) * 1986-12-31 1989-10-03 Alcon Laboratories, Inc. Means and method for dispensing substances
US4994028A (en) 1987-03-18 1991-02-19 Endocon, Inc. Injector for inplanting multiple pellet medicaments
US4846793A (en) * 1987-03-18 1989-07-11 Endocon, Inc. Injector for implanting multiple pellet medicaments
AU608891B2 (en) 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
JPH01139525A (ja) * 1987-11-27 1989-06-01 Sanwa Kagaku Kenkyusho Co Ltd 外用フィルム製剤及びその製法
US4954587A (en) * 1988-07-05 1990-09-04 Ciba-Geigy Corporation Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
DK0384646T3 (da) 1989-02-16 1993-07-12 British Tech Group Dispenseringsindretning
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5273752A (en) * 1989-07-18 1993-12-28 Alza Corporation Controlled release dispenser comprising beneficial agent
US5468811A (en) * 1989-11-02 1995-11-21 National Patent Development Corporation Hydrophilic composite polymer articles formed from a settable paste comprising a mixture of hydrophilic polymer and unsaturated monomer
JP2879695B2 (ja) * 1990-02-22 1999-04-05 日本曹達株式会社 口腔内粘膜付着性フィルム製剤
US5254662A (en) * 1990-09-12 1993-10-19 Polymedia Industries, Inc. Biostable polyurethane products
WO1992005775A1 (en) * 1990-09-28 1992-04-16 Pfizer Inc. Dispensing device containing a hydrophobic medium
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
AU652984B2 (en) 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
JP2530079B2 (ja) 1992-02-05 1996-09-04 ナショナル・パテント・ディベロプメント・コーポレーション 水分膨潤性親水性製品及び薬物放出装置の製造
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
DE69425781T2 (de) * 1993-06-11 2001-01-04 Nippon Chemi-Con Corp., Ome Understützungs- und Verbindungsgerät für einen Magnetfeldmodulationskopf, der in einer photomagnetischen Aufzeichnung benutzt wird
US5354835A (en) * 1993-07-23 1994-10-11 Saudi Basic Industries Corporation Desalination process
KR950007873A (ko) 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제
JPH07252166A (ja) 1993-09-20 1995-10-03 Shiseido Co Ltd 徐放性製剤
JPH0797338A (ja) 1993-09-20 1995-04-11 Shiseido Co Ltd 徐放性製剤
NL9401051A (nl) * 1994-06-24 1996-02-01 Stichting Tech Wetenschapp Microfoon op basis van fluidum-stroommeting en akoestische generator gebaseerd daarop.
JPH0839586A (ja) * 1994-07-27 1996-02-13 Banyu Pharmaceut Co Ltd 放出制御製剤組成物の製造方法
US6143718A (en) * 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
US5904935A (en) 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
CA2264562C (en) * 1996-08-30 2012-01-03 Peptech Limited Sustained peptide-release formulation
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
AUPO251096A0 (en) * 1996-09-23 1996-10-17 Cardiac Crc Nominees Pty Limited Polysiloxane-containing polyurethane elastomeric compositions
US5756127A (en) * 1996-10-29 1998-05-26 Wright Medical Technology, Inc. Implantable bioresorbable string of calcium sulfate beads
EP0996459B1 (en) * 1997-01-07 2005-09-21 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the reduction of food intake
US5854127A (en) * 1997-03-13 1998-12-29 Micron Technology, Inc. Method of forming a contact landing pad
FI971385A0 (fi) 1997-04-04 1997-04-04 Bioxid Oy Biokompatibel komposition, metoder foer dess framstaellning samt anvaendning daerav
US7101853B2 (en) * 1997-05-06 2006-09-05 Amylin Pharmaceuticals, Inc. Method for treating or preventing gastritis using amylin or amylin agonists
US7157555B1 (en) * 1997-08-08 2007-01-02 Amylin Pharmaceuticals, Inc. Exendin agonist compounds
US7220721B1 (en) * 1997-11-14 2007-05-22 Amylin Pharmaceuticals, Inc. Exendin agonist peptides
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
WO2000004037A1 (en) * 1998-07-14 2000-01-27 Amylin Pharmaceuticals, Inc. Uncoupling protein 4 (ucp-4) and methods of use
ES2402799T3 (es) * 1998-07-23 2013-05-09 Southern Research Institute Prepreparación de compuestos de tioarabinofuranosilo y utilización de los mismos
US6087334A (en) * 1998-08-21 2000-07-11 Amylin Pharmaceuticals, Inc. Anti-diabetic peptides
US20040071736A1 (en) * 1998-08-25 2004-04-15 Health Protection Agency Methods and compounds for the treatment of mucus hypersecretion
US7259136B2 (en) * 1999-04-30 2007-08-21 Amylin Pharmaceuticals, Inc. Compositions and methods for treating peripheral vascular disease
DK1143989T3 (da) * 1999-01-14 2007-04-16 Amylin Pharmaceuticals Inc Exendiner til glucagonundertrykkelse
AU757605B2 (en) 1999-01-28 2003-02-27 Indevus Pharmaceuticals, Inc. Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
CA2396157A1 (en) * 2000-01-10 2001-07-19 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
MXPA02009031A (es) * 2000-03-14 2004-08-19 Amylin Pharmaceuticals Inc Efectos del peptido-1(7-36) tipo glucagon en la motilidad antro-piloro.duodenal.
US6969480B2 (en) * 2000-05-12 2005-11-29 Matregen Corp. Method of producing structures using centrifugal forces
ATE397938T1 (de) * 2000-05-19 2008-07-15 Amylin Pharmaceuticals Inc Behandlung des akuten koronaren syndroms mit glp- 1
JP3498041B2 (ja) * 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
US7118737B2 (en) * 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
US8273713B2 (en) * 2000-12-14 2012-09-25 Amylin Pharmaceuticals, Llc Methods of treating obesity using PYY[3-36]
US20030049320A1 (en) 2000-12-18 2003-03-13 Wockhardt Limited Novel in-situ forming controlled release microcarrier delivery system
AU2002251448A1 (en) 2001-04-01 2002-10-15 Yeda Research And Development Co. Ltd. Weizmann Institute Of Science Oral absorbed drugs
US7105489B2 (en) * 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
ATE494002T1 (de) * 2002-06-14 2011-01-15 Amylin Pharmaceuticals Inc Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
US6942264B1 (en) * 2003-02-10 2005-09-13 Richard Mendez Disposable pet waste receptacle
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
WO2005041873A2 (en) 2003-10-24 2005-05-12 Azopax Therapeutics Llc Formulation of exendin-4
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
US8076288B2 (en) * 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
JP2005350424A (ja) * 2004-06-14 2005-12-22 Kyocera Chemical Corp 固形製剤および固形製剤の製造方法
EP1773293B1 (en) * 2004-06-17 2015-04-15 Endo Pharmaceuticals Solutions Inc. Compositions and methods for treating central precocious puberty
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
SE0402345L (sv) * 2004-09-24 2006-03-25 Mederio Ag Uppmätt läkemedelsdos
JP2006249175A (ja) * 2005-03-09 2006-09-21 Mitsubishi Engineering Plastics Corp ポリカーボネート樹脂組成物及びそれよりなる医療用器具
EP2455072A1 (en) * 2005-03-11 2012-05-23 Endo Pharmaceuticals Solutions Inc. Controlled release formulations of octreotide
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
FR2885813B1 (fr) * 2005-05-19 2008-01-11 Oreal Vectorisation de dsrna par des particules cationiques et leur utilisation sur modele de peau.
US9095630B2 (en) 2005-05-19 2015-08-04 L'oreal Vectorization of dsRNA by cationic particles and use of same on a skin model
US20070037897A1 (en) 2005-08-12 2007-02-15 Guigui Wang Method for making contact lenses
JP2009507050A (ja) 2005-09-08 2009-02-19 ガストロテック・ファルマ・アクティーゼルスカブ 胆道ジスキネジーおよび/または胆道痛/不快の治療のためのglp−1分子の使用
EP1942869A2 (en) * 2005-11-04 2008-07-16 Eastman Chemical Company Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances
MX2008009125A (es) * 2006-01-18 2008-10-23 Qps Llc Composiciones farmaceuticas con estabilidad mejorada.
WO2008061355A1 (en) * 2006-11-24 2008-05-29 Matregen Corp. Glp-1 depot systems, and methods of manufacture and uses thereof
MX2009011641A (es) * 2007-04-27 2010-03-04 Endo Pharmaceuticals Solutions Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.

Similar Documents

Publication Publication Date Title
JP2011526288A5 (https=)
Zheng et al. Hydrogel-mediated extracellular vesicles for enhanced wound healing: the latest progress, and their prospects for 3D bioprinting
You et al. Ultrarapid‐Acting Microneedles for Immediate Delivery of Biotherapeutics
JP5622725B2 (ja) エキセナチド及び他のポリペプチド類の持続的送達
EP2073854B1 (en) Hydrogel wound dressing and biomaterials formed in situ and their uses
Gao et al. PEGDA/PVP microneedles with tailorable matrix constitutions for controllable transdermal drug delivery
JP5855826B2 (ja) デバイス、及びレザバーインプラントデバイスの製造方法
KR101858451B1 (ko) 건식 시트형 마스크 팩용 조성물 및 건식 시트형 마스크 팩의 제조방법
CN111956596A (zh) 一种响应性释放药物微针贴片及其制备方法
US20230381096A1 (en) Core-shell microneedle patch for h2o2 and ph cascade-triggered insulin delivery
Wang et al. Living microecological microneedle patches enable proregenerative microenvironmental remodeling for promoting infected diabetic wound healing
US12161749B2 (en) Microneedle-array patches with glucose-responsive matrix for closed-loop insulin delivery
JP6139259B2 (ja) 創傷治療剤の製造方法
Zhu et al. 3D printed ion-responsive personalized transdermal patch
Saleem et al. Narrative review on nanoparticles based on current evidence: therapeutic agents for diabetic foot infection
Zhu et al. Estriol dissolving microneedle patches for protection against ionizing radiation-induced injury
ES2398360T3 (es) Proceso de recubrimiento de microesferas sobre un material flexible
JP2004538300A (ja) 皮膚又は粘膜上の適用に関する有効成分を含有する粒子を含む剤形
JP3227462B2 (ja) 均一ヒドロゲルコポリマーの製法
CN116421544A (zh) 聚合物微针、微针片及含其的递送系统、制备方法、应用
KR102905855B1 (ko) 필러 조성물 및 이를 이용한 필러 시술 방법
Nguyen-Thi et al. Advanced in Co-Delivery, Controllable Therapy using Microneedle: From Design to Therapeutic Effects
Zekri New Treatments for Management of Diabetic Foot Ulcers
CN120899618A (zh) 载镁脱细胞羊膜微针及其制备方法
CN121927195A (zh) 一种具有光热转换功能的双网络水凝胶微针及其制备方法和应用